US-based biotech company Regeneron Pharmaceuticals intends to buy the assets of genetics-led consumer healthcare and biotech company 23andMe in a bankruptcy auction, both companies announced on Monday.
Private equity firm Brookfield Business Partners is handing control of its financially troubled Australian hospital asset Healthscope to creditors, in a move not far off a (de facto) bankruptcy process. Meanwhile Healthscope’s main competitor in the Aussie hospital market, Ramsay Health Care, has hinted it might be interested in acquiring the group.
The merger of two of Europe’s largest listed healthcare REITs, Aedifica and Cofinimmo, to create a giant pan-European healthcare REIT with ~€11 billion healthcare assets under management (AUM), may still be on the table. Cofinimmo's board unanimously rejected Aedifica’s offer for the REIT but has suggested it would accept a higher offer.
VAMED care, a German rehab group owned by French private equity firm PAI Partners, has acquired the rehab clinics of Paracelsus, another German provider. The intention is to fully combine the groups and create a new major German rehab brand with a care network of 50 facilities.
Vespa Capital, a UK private equity firm focused on lower mid-market investments, has invested in FibroFind, a contract research organisation that has a patented technology which enables testing to be carried out on human tissue rather than animals.
The UK’s Competition and Markets Authority (CMA) has proposed measures to increase price transparency in the UK’s veterinary sector, and even suggested limited price controls. Shares of listed veterinary groups jumped up, however, as the proposed measures did not include much-feared forced asset sales.
RWK BidCo, a newly formed company wholly owned by global investment firm KKR Funds with the purpose of making the offer in deals, has announced a recommended public offer to the shareholders of Biotage, valuing it at around 1.6 billion SEK ($1.22 billion).
DCC, A Dublin-based and London Stock Exchange-listed sales, marketing and support services group, has announced it has entered into a definitive agreement to sell its healthcare division to HealthCo, an investment vehicle of funds managed by European private equity firm Investindustrial Advisors, for £1.05 billion (approximately €1.23 billion).
Generali Investments, a platform of asset management firms with €645.2 billion in assets under management (as of December 31, 2024) together with Partners Group, a Swiss-based global private equity firm, are launching a new private credit secondaries fund. The launch of Generali Investments' ‘Private Credit Secondaries Fund’ signals not only the growing maturity of the private credit market but also its strategic importance for sectors like healthcare.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
